Sponsor Pipeline

NeuroGenesis Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06961383 Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis Secondary Progressive Multiple Sclerosis (SPMS) Not Yet Recruiting
Disease Areas
Multiple Sclerosis (1)
Get alerts when NeuroGenesis Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free